Regulatory press release18.06.2024 klo 20.00Cline Scientific: Communiqué from the Annual General Meeting
Regulatory press release26.05.2024 klo 10.15Annual Report for Cline Scientific AB (publ), 556867-8238, for the period 1 January - 31 December 2023
Regulatory press release16.05.2024 klo 09.30Notice to the Annual General Meeting of Cline Scientific AB
Regulatory press release30.04.2024 klo 11.05Cline Scientific provides an update on the company's financial position
Press release15.03.2024 klo 09.45BioStock: Scientific Advisor on the potential of Cline's cell therapy for cartilage damage
Press release01.03.2024 klo 09.30Cline: StemCART updates on achieved milestones on the way to phase 1 study
Regulatory press release23.02.2024 klo 09.30Bokslutskommuniké for Cline Scientific AB (publ), 556867-8238, for the period 1 January - 31 December 2023
Press release13.02.2024 klo 09.30Cline Scientific advisor discusses the future of cartilage damage treatment
Regulatory press release18.01.2024 klo 21.12Cline Scientific provides an update on the company's financial position
Press release18.01.2024 klo 20.15Cline Scientific provides an update on the company's financial position
Press release22.12.2023 klo 13.13Cline: Medtech4Health supports capacity building in the strategy and regulatory pathway for StemCART
Press release08.12.2023 klo 13.00CORRECTION: Newsletter December 2023 - Summing up the year with a Christmas message and Cline's bright view of the future
Press release07.12.2023 klo 14.03Newsletter December 2023 - Summing up the year with a Christmas message and Cline's bright view of the future
Press release21.11.2023 klo 12.18Judgment in the market manipulation case against Cline Scientific's CEO Patrik Sundh